Ann: US FDA Grants Approval for APAS-LBT.AX, page-1206

With a average VWAP over the past 10 days at .76 cents I cant imagine who will be selling to you at .48 cents. New investors have paid a significantly higher price range and have a new set of expectations. Early bird investors would be largely free carried and with nothing but a positive outlook have no major reason to sell. Volumes significantly lower today during the retrace. Range has tightened also. Manipulation still evident. Almost certainly parcels of shares being passed from left hand to right by the crooks. First announcement on commercialisation will likely retest highs. A close over a dollar will open the floodgates to much higher prices imo. Really disappointed I missed this one pre FDA announcement.Was grossly undervalued imo. Potentially a future blue chip. Big chance imo.